drugset / Trial / NCT02614872
Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the safety and efficacy of intravenous GLASSIA® treatment in lung transplantation.
Timeline
- Start
- 2016-07-26
- Primary completion
- 2019-04-11
- Completion
- 2019-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alpha 1-Antitrypsin | Protein / enzyme biologic | — | Intravenous |